← Evidence map

ArticleHemaSphere2026

Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study.

Nicola Polverelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study. | OpenQuestion